Cisen Pharmaceutical Co., Ltd.
SHH: 603367.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhenxin Du
- Employees
- 3,402
- Headquarters
- Jining, China
- IPO year
- 2017
- Market cap
- CN¥7.1B
- Website
- https://www.lkcisen.com
Loading 603367…
Loading profile data…Frequently asked questions about 603367
What does Cisen Pharmaceutical Co., Ltd. (603367.SS) do?
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents...
Where does 603367.SS trade?
Cisen Pharmaceutical Co., Ltd. (603367.SS) trades on the Shanghai Stock Exchange.
What sector is 603367.SS in?
Cisen Pharmaceutical Co., Ltd. (603367.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Cisen Pharmaceutical Co., Ltd.?
Zhenxin Du is the chief executive officer of Cisen Pharmaceutical Co., Ltd. (603367.SS).
Where is Cisen Pharmaceutical Co., Ltd. headquartered?
Cisen Pharmaceutical Co., Ltd. is headquartered in China.
Does 603367.SS pay a dividend?
Yes — Cisen Pharmaceutical Co., Ltd. (603367.SS) paid a trailing twelve-month dividend of CNY 0.41 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603367.SS go public?
Cisen Pharmaceutical Co., Ltd. (603367.SS) completed its initial public offering in 2017.